Product Name :
Zika virus E protein ectodomain（ZIKV-E） Background :
Zika virus (ZIKV) is an arbovirus belonging to the genus Flavivirus (Family Flaviviridae) and was first described in 1947 in Uganda following blood analyses of sentinelRhesusmonkeys1. Until the 20thcentury, the African and Asian lineages of the virus did not cause meaningful infections in humans. However, in 2007, vectored byAedes aegyptimosquitoes, ZIKV caused the first noteworthy epidemic on the island of Yap in Micronesia2. Patients experienced fever, skin rash, arthralgia and conjunctivitis2. Zika is spread mostly by the bite of an infected Aedes species mosquito (Ae. aegypti and Ae. albopictus). These mosquitoes bite during the day and night. Zika can be passed from a pregnant woman to her fetus. Infection during pregnancy can cause certain birth defects. There is no vaccine or medicine for Zika. Product :
Inclusion body;0.5mol Urea,PH=8 Storage&Stability :
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles. Specificity :
Carrier:pET30a-ZIKV-E-His(C-term) Virus:Zika virus isolate VE_Ganxian Immunogen :
pathway :

• 
  Zika virus E protein ectodomain, His Tag on SDS-PAGE under reducing (R) condition. The gel was stained overnight with Coomassie Blue. The purity of the protein is greater than 85%.

Blocking peptide available as NCP0142P